Nurix Therapeutics

Nurix Therapeutics is one of the...

• Russell 3000.

Nurix Therapeutics is a company listed under the stock ticker NRIX (US).

Acquisition, funding and merger involving Nurix Therapeutics.

• Nurix Therapeutics has just announced a $175 Million fundraising (posted on April 13 2024).

View the org chart displaying its 28 main executives

Most searched biographies at Nurix Therapeutics

• Arthur Sands, Chief Executive Officer and Director
• Judith Reinsdorf, Director
• Edward Saltzman, Director

Create your alert
to follow the executive moves at Nurix Therapeutics.

Nurix Therapeutics has 2,280 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Metsera has just announced a $290 Million fundraising (posted on April 23 2024).
• Histogen has filed for bankruptcy protection  (posted on April 19 2024).
• Bruker has announced the acquisition of NanoString Technologies  (posted on April 18 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Vik Bajaj - Director at Interline Therapeutics
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by Nurix Therapeutics

• Nurix Therapeutics Announces Appointment of Eric Schlezinger, J.D. as Chief People Officer | Nurix Therapeutics, Inc.
• Press Releases | Nurix Therapeutics, Inc.
• Press Releases | Nurix Therapeutics, Inc.
• Press Releases | Nurix Therapeutics, Inc.
• Nurix Therapeutics Announces $40 Million Registered Direct Offering | Nurix Therapeutics, Inc.
• Press Releases | Nurix Therapeutics, Inc.
• Nurix Therapeutics Announces $55 Million Registered Direct Offering | Nurix Therapeutics, Inc.
• Nurix Therapeutics Reports Fiscal Second Quarter 2022 Financial Results and Provides a Corporate Update | Nurix Therapeutics, Inc.
• Nurix Therapeutics Announces Clearance of Investigational New Drug Application For NX-1607 Supporting Plans to Expand Enrollment to U.S. Clinical Sites | Nurix Therapeutics, Inc.
• Press Releases | Nurix Therapeutics, Inc.
• View more press releases Close

Social media about Nurix Therapeutics

• Nurix Therapeutics on Wikipedia, Google News & Yahoo Finance
• Nurix Therapeutics on LinkedIn, Twitter & YouTube

Contact by email its executives including Edward Saltzman

Call Nurix Therapeutics at +1 415...

View the org chart

Register to receive your alert

Report an error